Jane Preuss Hasselby

Jane Preuss Hasselby

Clinical Associate Professor


  1. 2023
  2. Published

    Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)

    Chen, I. M., Donia, M., Chamberlain, C. A., Jensen, Agnete Witness Præst, Draghi, A., Theile, S., Madsen, K., Hasselby, Jane Preuss, Toxværd, A., Høgdall, Estrid Vilma Solyom, Lorentzen, T., Wilken, E. E., Geertsen, P., Svane, Inge Marie, Johansen, Julia Sidenius & Nielsen, D., 2023, In: European Journal of Cancer. 180, p. 125-133 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy

    Mortensen, R. E. J., Holmström, M. O., Lisle, T. L., Hasselby, Jane Preuss, Willemoe, G. L., Met, Özcan, Svane, Inge Marie, Johansen, Julia Sidenius, Nielsen, Dorte Lisbet, Chen, I. M. & Andersen, Mads Hald, 2023, In: Journal for ImmunoTherapy of Cancer. 11, 3

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Prognostic significance of margin clearance in pancreaticoduodenectomy specimens with pancreatic ductal adenocarcinoma in a Danish population-based nationwide study

    Aaquist, T., Fristrup, C. W., Hasselby, Jane Preuss, Hamilton-Dutoit, S., Eld, M., Pfeiffer, P., Mortensen, M. B. & Detlefsen, S., 2023, In: HPB. 25, 7, p. 826-835 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancer

    Lindgaard, S. C., Sztupinszki, Z., Maag, E., Hansen, C. P., Chen, I. M., Johansen, A. Z., Hasselby, Jane Preuss, Bojesen, Stig Egil, Nielsen, D. & Johansen, Julia Sidenius, 2023, In: Cancer Medicine. 12, 4, p. 3972-3986

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma

    Stubbe, B. E., Larsen, A. C., Madsen, P. H., Krarup, H. B., Pedersen, I. S., Lundbye-Christensen, S., Hansen, C. P., Hasselby, Jane Preuss, Johansen, A. Z., Thorlacius-Ussing, O., Johansen, Julia Sidenius & Henriksen, S. D., 2023, In: Frontiers in Oncology. 13, 11 p., 1211292.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Targeted next-generation sequencing of EUS-guided through-the-needle-biopsy sampling from pancreatic cystic lesions

    Rift, C. V., Melchior, L. C., Kovacevic, B., Klausen, P., Toxværd, A., Grossjohann, Hanne Sønder, Karstensen, John Gásdal, Brink, L., Hassan, H., Kalaitzakis, E., Storkholm, J., Scheie, David, Hansen, C. P., Lund, Eva Løbner, Vilmann, Peter & Hasselby, Jane Preuss, 2023, In: Gastrointestinal Endoscopy. 97, 1, p. 50-58.e4

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer

    Grützmeier, S. E., Kovacevic, B., Vilmann, Peter, Rift, Charlotte Vestrup, Melchior, L. C., Holmström, M. O., Brink, L., Hassan, H., Karstensen, John Gásdal, Grossjohann, Hanne Sønder, Chiranth, D., Toxværd, A., Hansen, C. P., Høgdall, Estrid Vilma Solyom, Hasselby, Jane Preuss & Klausen, P., 2023, In: Cancers. 15, 14, 18 p., 3677.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 33970273